Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016 (2016), Article ID 6865758, 7 pages
http://dx.doi.org/10.1155/2016/6865758
Review Article

Immunoregulatory Role of HLA-G in Allergic Diseases

1Department of Internal Medicine, Scleroderma Unit, Clinical Immunology Unit, University of Genova, 16132 Genova, Italy
2Department of Internal Medicine, Respiratory and Allergy Diseases Unit, University of Genova, 16132 Genova, Italy

Received 26 April 2016; Accepted 25 May 2016

Academic Editor: Nathalie Rouas-Freiss

Copyright © 2016 Giuseppe Murdaca et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. L. Ploegh, H. T. Orr, and J. L. Strominger, “Major histocompatibility antigens: the human (HLA-A,-B,-C) and murine (H-2K, H-2D) class I molecules,” Cell, vol. 24, no. 2, pp. 287–299, 1981. View at Publisher · View at Google Scholar · View at Scopus
  2. C. A. O'Callaghan and J. I. Bell, “Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G,” Immunological Reviews, vol. 163, pp. 129–138, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Nicolae, N. J. Cox, L. A. Lester et al., “Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21,” American Journal of Human Genetics, vol. 76, no. 2, pp. 349–357, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. A. Ellis, I. L. Sargent, C. W. G. Redman, and A. J. McMichael, “Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line,” Immunology, vol. 59, no. 4, pp. 595–601, 1986. View at Google Scholar · View at Scopus
  5. S. A. Ellis, M. S. Palmer, and A. J. McMichael, “Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule,” The Journal of Immunology, vol. 144, no. 2, pp. 731–735, 1990. View at Google Scholar · View at Scopus
  6. D. E. Geraghty, B. H. Koller, and H. T. Orr, “A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 24, pp. 9145–9149, 1987. View at Publisher · View at Google Scholar · View at Scopus
  7. D. T. Umetsu and R. H. DeKruyff, “The regulation of allergy and asthma,” Immunological Reviews, vol. 212, pp. 238–255, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Murdaca, P. Contini, M. Setti et al., “Soluble human leukocyte antigen-G serum levels in patients with acquired immune deficiency syndrome affected by different disease-defining conditions before and after antiretroviral treatment,” Human Immunology, vol. 72, no. 9, pp. 712–716, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Murdaca, P. Contini, M. Setti et al., “Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A,-B,-C antigens and potential role in immune-reconstitution,” Clinical Immunology, vol. 133, no. 2, pp. 238–244, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Favier, J. LeMaoult, N. Rouas-Freiss, P. Moreau, C. Menier, and E. D. Carosella, “Research on HLA-G: an update,” Tissue Antigens, vol. 69, no. 3, pp. 207–211, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. E. D. Carosella, B. Favier, N. Rouas-Freiss, P. Moreau, and J. Lemaoult, “Beyond the increasing complexity of the immunomodulatory HLA-G molecule,” Blood, vol. 111, no. 10, pp. 4862–4870, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. H. Larsen and T. V. F. Hviid, “Human leukocyte antigen-G polymorphism in relation to expression, function, and disease,” Human Immunology, vol. 70, no. 12, pp. 1026–1034, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Shiroishi, K. Kuroki, T. Ose et al., “Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer,” The Journal of Biological Chemistry, vol. 281, no. 15, pp. 10439–10447, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Apps, L. Gardner, A. M. Sharkey, N. Holmes, and A. Moffett, “A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1,” European Journal of Immunology, vol. 37, no. 7, pp. 1924–1937, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. R. White, “Human leucocyte antigen-G: expression and function in airway allergic disease,” Clinical and Experimental Allergy, vol. 42, no. 2, pp. 208–217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. E. D. Carosella, P. Moreau, J. Le Maoult, M. Le Discorde, J. Dausset, and N. Rouas-Freiss, “HLA-G molecules: from maternal-fetal tolerance to tissue acceptance,” Advances in Immunology, vol. 81, pp. 199–252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Rebmann, A. Busemann, M. Lindemann, and H. Grosse-Wilde, “Detection of HLA-G5 secreting cells,” Human Immunology, vol. 64, no. 11, pp. 1017–1024, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. J. Castro, P. Morales, J. Martínez-Laso et al., “Evolution of MHC-G in humans and primates based on three new 3'UT polymorphisms,” Human Immunology, vol. 61, no. 11, pp. 1157–1163, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. G. A. Harrison, K. E. Humphrey, I. B. Jakobsen, and D. W. Cooper, “A 14 bp deletion polymorphism in the HLA-G gene,” Human Molecular Genetics, vol. 2, no. 12, article 2200, 1993. View at Google Scholar · View at Scopus
  20. X.-Y. Chen, W.-H. Yan, A. Lin, H.-H. Xu, J.-G. Zhang, and X.-X. Wang, “The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma,” Tissue Antigens, vol. 72, no. 4, pp. 335–341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Piancatelli, D. Maccarone, G. Liberatore et al., “HLA-G 14-bp insertion/deletion polymorphism in kidney transplant patients with metabolic complications,” Transplantation Proceedings, vol. 41, no. 4, pp. 1187–1188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. E. C. Castelli, C. T. Mendes-Junior, N. H. S. Deghaide et al., “The genetic structure of 3′untranslated region of the HLA-G gene: polymorphisms and haplotypes,” Genes and Immunity, vol. 11, no. 2, pp. 134–141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Rousseau, M. Le Discorde, G. Mouillot, C. Marcou, E. D. Carosella, and P. Moreau, “The 14 bp deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences HLA-G mRNA stability,” Human Immunology, vol. 64, no. 11, pp. 1005–1010, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. S.-M. Yie, L.-H. Li, R. Xiao, and C. L. Librach, “A single base-pair mutation in the 3′-untranslated region of HLA-G mRNA is associated with pre-eclampsia,” Molecular Human Reproduction, vol. 14, no. 11, pp. 649–653, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Tan, G. Randall, J. Fan et al., “Allele-specific targeting of microRNAs to HLA-G and risk of asthma,” American Journal of Human Genetics, vol. 81, no. 4, pp. 829–834, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. E. A. Donadi, E. C. Castelli, A. Arnaiz-Villena, M. Roger, D. Rey, and P. Moreau, “Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association,” Cellular and Molecular Life Sciences, vol. 68, no. 3, pp. 369–395, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Yang, W. Chu, D. E. Geraghty, and J. S. Hunt, “Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-γ,” The Journal of Immunology, vol. 156, no. 11, pp. 4224–4231, 1996. View at Google Scholar · View at Scopus
  28. P. Moreau, F. Adrian-Cabestre, C. Menier et al., “IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes,” International Immunology, vol. 11, no. 5, pp. 803–811, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Romagnani, “Biology of human TH1 and TH2 cells,” Journal of Clinical Immunology, vol. 15, no. 3, pp. 121–129, 1995. View at Publisher · View at Google Scholar · View at Scopus
  30. S. R. Durham, S. Ying, V. A. Varney et al., “Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia,” The Journal of Immunology, vol. 148, no. 8, pp. 2390–2394, 1992. View at Google Scholar · View at Scopus
  31. R. P. Schleimer, S. A. Sterbinsky, J. Kaiser et al., “IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1,” Journal of Immunology, vol. 148, no. 4, pp. 1086–1092, 1992. View at Google Scholar · View at Scopus
  32. O. M. Kon and A. Kay, “T cells and chronic asthma,” International Archives of Allergy and Immunology, vol. 118, no. 2–4, pp. 133–135, 1999. View at Publisher · View at Google Scholar
  33. M. Imada, F. Estelle, R. Simons, F. T. Jay, and K. T. HayGlass, “Allergen-stimulated interleukin-4 and interferon-γ production in primary culture: responses of subjects with allergic rhinitis and normal controls,” Immunology, vol. 85, no. 3, pp. 373–380, 1995. View at Google Scholar · View at Scopus
  34. G. Ciprandi, D. Fenoglio, I. Cirillo et al., “Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report,” Annals of Allergy, Asthma and Immunology, vol. 95, no. 1, pp. 38–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Ciprandi, B. M. Colombo, P. Contini et al., “Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis,” Allergy, vol. 63, no. 10, pp. 1335–1338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Ciprandi, P. Contini, G. Murdaca, A. M. Gallina, and F. Puppo, “Soluble HLA-G molecule in patients with perennial allergic rhinitis,” International Archives of Allergy and Immunology, vol. 150, no. 3, pp. 278–281, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Ciprandi, P. Contini, G. Murdaca, M. DeAmici, A. M. Gallina, and F. Puppo, “Soluble serum HLA-G and HLA-A, -B, -C molecules in patients with seasonal allergic rhinitis exposed to pollens,” International Immunopharmacology, vol. 9, no. 9, pp. 1058–1062, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. P. J. Bousquet, C. Combescure, F. Neukirch et al., “Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines,” Allergy, vol. 62, no. 4, pp. 367–372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Ciprandi, A. Corsico, and P. Pisati, “Serum-soluble HLA-G is associated with specific IgE in patients with allergic rhinitis and asthma,” Inflammation, vol. 37, no. 5, pp. 1630–1634, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Ciprandi and M. DeAmici, “Soluble HLA-G serum levels depend on allergy type and IgE levels,” Allergy & Rhinology, vol. 5, no. 1, pp. 9–11, 2014. View at Publisher · View at Google Scholar
  41. G. Ciprandi, M. De Amici, S. Caimmi et al., “Soluble serum HLA-G in children with allergic rhinitis and asthma,” Journal of Biological Regulators and Homeostatic Agents, vol. 24, no. 2, pp. 221–224, 2010. View at Google Scholar · View at Scopus
  42. G. Passalacqua and S. R. Durham, “Allergic rhinitis and its impact on asthma update: allergen immunotherapy,” Journal of Allergy and Clinical Immunology, vol. 119, no. 4, pp. 881–891, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Ciprandi, P. Continia, D. Fenoglio et al., “Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-γ production after sublingual immunotherapy in patients with allergic rhinitis,” Human Immunology, vol. 69, no. 7, pp. 409–413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Ciprandi, P. Contini, A. Pistorio, G. Murdaca, and F. Puppo, “Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis,” International Immunopharmacology, vol. 9, no. 2, pp. 253–257, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. P. K. Jeffery, “Remodeling in asthma and chronic obstructive lung disease,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 10, part 2, pp. S28–S38, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. P. K. Jeffery, A. J. Wardlaw, F. C. Nelson, J. V. Collins, and A. B. Kay, “Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity,” American Review of Respiratory Disease, vol. 140, no. 6, pp. 1745–1753, 1989. View at Publisher · View at Google Scholar · View at Scopus
  47. B. L. Bradley, M. Azzawi, M. Jacobson et al., “Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness,” The Journal of Allergy and Clinical Immunology, vol. 88, no. 4, pp. 661–674, 1991. View at Publisher · View at Google Scholar · View at Scopus
  48. S. T. Holgate, “The airway epithelium is central to the pathogenesis of asthma,” Allergology International, vol. 57, no. 1, pp. 1–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. I. R. Mackay, F. S. Rosen, and A. B. Kay, “Advances in Immunology: allergy and allergic diseases: second of two parts,” The New England Journal of Medicine, vol. 344, no. 2, pp. 109–113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Ober and S. Hoffjan, “Asthma genetics 2006: the long and winding road to gene discovery,” Genes and Immunity, vol. 7, no. 2, pp. 95–100, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. Z. Tan, A. M. Shon, and C. Ober, “Evidence of balancing selection at the HLA-G promoter region,” Human Molecular Genetics, vol. 14, no. 23, pp. 3619–3628, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Naidoo, A. C. Wu, M. H. Brilliant et al., “A polymorphism in HLA-G modifies statin benefit in asthma,” Pharmacogenomics Journal, vol. 15, no. 3, pp. 272–277, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Granada, J. B. Wilk, M. Tuzova et al., “A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study,” Journal of Allergy and Clinical Immunology, vol. 129, no. 3, pp. 840.e21–845.e21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Rajagopalan, J. Fu, and E. O. Long, “Cutting edge: induction of IFN-γ production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells,” The Journal of Immunology, vol. 167, no. 4, pp. 1877–1881, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. W. H. Yan and L. A. Fan, “Residues Met76 and Gln79 in HLA-G α1 domain involved in KIR2DL4 recognition,” Cell Research, vol. 15, no. 3, pp. 176–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Rajagopalan, Y. T. Bryceson, S. P. Kuppusamy et al., “Activation of NK cells by an endocytosed receptor for soluble HLA-G,” PLoS Biology, vol. 4, no. 1, article e9, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Cantoni, S. Verdiani, M. Falco et al., “p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily,” European Journal of Immunology, vol. 28, no. 6, pp. 1980–1990, 1998. View at Publisher · View at Google Scholar
  58. Y.-R. Yu, X.-H. Tian, Y. Wang, and M.-F. Feng, “Rapid production of human KIR2DL4 extracellular domain and verification of its interaction with HLA-G,” Biochemistry, vol. 71, supplement 1, pp. S60–S65, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. P. Vacca, C. Cantoni, M. Vitale et al., “Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 26, pp. 11918–11923, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. M. E. L. Le Page, J. P. Goodridge, G. Zhang, P. G. Holt, P. Sly, and C. S. Witt, “Genetic polymorphism of KIR2DL4 (CD158d), a putative NK cell receptor for HLA-G, does not influence susceptibility to asthma,” Tissue Antigens, vol. 82, no. 4, pp. 276–279, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. F. Tahan and T. Patiroglu, “Plasma soluble human leukocyte antigen G levels in asthmatic children,” International Archives of Allergy and Immunology, vol. 141, no. 3, pp. 213–216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. X.-Q. Zheng, C.-C. Li, D.-P. Xu et al., “Analysis of the plasma soluble human leukocyte antigen-G and interleukin-10 levels in childhood atopic asthma,” Human Immunology, vol. 71, no. 10, pp. 982–987, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. C. E. Mapp, S. Ferrazzoni, R. Rizzo et al., “Soluble human leucocyte antigen-G and interleukin-10 levels in isocyanate-induced asthma,” Clinical & Experimental Allergy, vol. 39, no. 6, pp. 812–819, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Rizzo, M. Stignani, P. Amoudruz et al., “Allergic women have reduced sHLA-G plasma levels at delivery,” American Journal of Reproductive Immunology, vol. 61, no. 5, pp. 368–376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Imai, T. Yoshida, M. Baba, M. Nishimura, M. Kakizaki, and O. Yoshie, “Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector,” Journal of Biological Chemistry, vol. 271, no. 35, pp. 21514–21521, 1996. View at Publisher · View at Google Scholar · View at Scopus
  66. H. Miyahara, N. Okazaki, T. Nagakura, S. Korematsu, and T. Izumi, “Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy,” Clinical and Experimental Allergy, vol. 41, no. 2, pp. 186–191, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Akdis, C. A. Akdis, L. Weigl, R. Disch, and K. Blaser, “Skin-homing, CLA+ memory T Cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated ctokine pattern: IgG4 counter-regulation by CLA- memory T cells,” Journal of Immunology, vol. 159, no. 9, pp. 4611–4619, 1997. View at Google Scholar · View at Scopus
  68. K. Khosrotehrani, C. Le Danff, B. Reynaud-Mendel, L. Dubertret, E. D. Carosella, and S. Aractingi, “HLA-G expression in atopic dermatitis,” Journal of Investigative Dermatology, vol. 117, no. 3, pp. 750–752, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Aractingi, N. Briand, C. Le Danff et al., “HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?” The American Journal of Pathology, vol. 159, no. 1, pp. 71–77, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Menier, N. Rouas-Freiss, B. Favier, J. Lemaoult, P. Moreau, and E. D. Carosella, “Recent advances on the non-classical major histocompatibility complex class i HLA-G molecule,” Tissue Antigens, vol. 75, no. 3, pp. 201–206, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. G. Murdaca, P. Contini, M. Setti et al., “Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome,” Human Immunology, vol. 68, no. 11, pp. 894–900, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. N. Rouas-Freiss, A. Naji, A. Durrbach, and E. D. Carosella, “Tolerogenic functions of human leukocyte antigen G: from pregnancy to organ and cell transplantation,” Transplantation, vol. 84, no. 1, pp. S21–S25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. E. D. Carosella, S. Gregori, N. Rouas-Freiss, J. Lemaoult, C. Menier, and B. Favier, “The role of HLA-G in immunity and hematopoiesis,” Cellular and Molecular Life Sciences, vol. 68, no. 3, pp. 353–368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. C. Bachert, M. van Kempen, and P. van Cauwenberge, “Regulation of proinflammatory cytokines in seasonal allergic rhinitis,” International Archives of Allergy and Immunology, vol. 118, no. 2–4, pp. 375–379, 1999. View at Publisher · View at Google Scholar · View at Scopus
  75. E. D. Carosella, S. Gregori, and J. LeMaoult, “The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells,” Blood, vol. 118, no. 25, pp. 6499–6505, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. J.-H. Lee, H.-H. Yu, L.-C. Wang, Y.-H. Yang, Y.-T. Lin, and B.-L. Chiang, “The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma,” Clinical & Experimental Immunology, vol. 148, no. 1, pp. 53–63, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. E. D. Carosella, N. Rouas-Freiss, D. T.-L. Roux, P. Moreau, and J. LeMaoult, “HLA-G: an immune checkpoint molecule,” Advances in Immunology, vol. 127, pp. 33–144, 2015. View at Publisher · View at Google Scholar · View at Scopus